RCE in Maxum Rumpus
CVE-2020-27575
Maxum Rumpus 8.2.13 and 8.2.14 is affected by a command injection vulnerability. The web administration contains functionality in which administrators are able to manage users. The edit users form contains a parameter vulnerable to command injection due to insufficient validation.
Vulnerability class: Command Injection (OS Command Injection)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.031 (87.2th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 87th percentile — 87.2% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.031 · newest: 0.031 · change: 0.000
Affected products
- Maxum Rumpus — versions 8.2.13, 8.2.14
Weakness classification (CWE)
Public proof-of-concept exploits
References
- af854a3a-2127-422b-91ae-364da2661108 (Product)
- tvrbk.github.io/cve/2021/03/07/rumpus.html (Exploit, Third Party Advisory)
Frequently asked questions
- What is CVE-2020-27575?
- CVE-2020-27575 is a high-severity vulnerability in Maxum Rumpus, classified under OS Command Injection. CVSS score: 8.8/10. Published 2021-03-08.
- How severe is CVE-2020-27575?
- High severity. CVSS v3 base score is 8.8 out of 10.
- Is CVE-2020-27575 known to be exploited?
- 2 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.